THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH

FLUORODOPA F18

Manufacturer:

THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH

Fluorodopa F18 HCPCS:

A9602

HCPCS Code Descriptor:

Fluorodopa f-18, diagnostic, per millicurie

Category:

A Code

Fluorodopa F18 NDCs:

13267-0346-57

Primary Type:

Imaging/Radiopharmaceutical

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

13267-0346-57

About Fluorodopa F18:

FLUORODOPA F18 is an Imaging/Radiopharmaceutical drug manufactured by THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH and administered via the Intravenous route of administration. The A Code: A9602 is aligned to the drug FLUORODOPA F18.

ACCESS PRICING AND MORE BY REGISTERING

A9602 Added Date:

October 1, 2022

A9602 Effective Date:

October 1, 2022

A9602 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Fluorodopa F18 billing and coding information.
Our team did not identify a source for Fluorodopa F18 patient assistance information. Please reach out to our team if you feel that this is a mistake.
FLUORODOPA F18 prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for FLUORODOPA F18. Please check back in a few weeks.